ANCHOR CAPITAL ADVISORS LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 132 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ANCHOR CAPITAL ADVISORS LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q2 2018$944,000
+0.4%
8,160
-14.3%
0.04%
+6.1%
Q1 2018$940,000
-15.2%
9,519
-10.0%
0.03%
-15.4%
Q4 2017$1,108,000
-9.9%
10,579
-3.1%
0.04%
-11.4%
Q3 2017$1,230,000
-47.1%
10,918
-47.3%
0.04%
-48.2%
Q2 2017$2,323,000
-3.6%
20,733
+0.4%
0.08%
+1.2%
Q1 2017$2,409,000
+42.5%
20,656
+28.6%
0.08%
+31.2%
Q4 2016$1,691,000
-1.7%
16,060
+3.2%
0.06%
+10.3%
Q3 2016$1,720,000
+8.5%
15,561
+42.9%
0.06%
+45.0%
Q2 2016$1,585,000
-0.8%
10,887
-2.3%
0.04%
+5.3%
Q1 2016$1,597,00011,1470.04%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q3 2017
NameSharesValueWeighting ↓
Claret Asset Management Corp 86,474$6,524,0001.34%
Analyst IMS Investment Management Services Ltd. 28,438$2,143,0000.64%
ALGERT GLOBAL LLC 20,876$1,575,0000.59%
Quantinno Capital Management LP 9,351$706,0000.48%
Crestline Management, LP 37,000$2,792,0000.45%
Empirical Finance, LLC 9,561$721,0000.20%
BRANDES INVESTMENT PARTNERS, LP 55,065$5,469,0000.14%
FORT, L.P. 9,672$730,0000.14%
CAXTON ASSOCIATES LP 8,865$669,0000.13%
ACADIAN ASSET MANAGEMENT LLC 330,448$24,928,0000.11%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders